Skip to main content

Want a detailed portfolio tracker?

Ascendis Pharma A/S (ASND) P/E (2015 - 2026)

Ascendis Pharma A/S (ASND) P/E from Jan 28, 2015 to Jul 21, 2026. The TTM Ascendis Pharma A/S (ASND) P/E is 28.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ascendis Pharma A/S (ASND)

YearP/EChange
202628.59-156.73%
2025-50.39+158.97%
2024-19.46+77.22%
2023-10.98-17.47%
2022-13.30-18.21%
2021-16.27-7.04%
2020-17.50-34.00%
2019-26.51+58.09%
2018-16.77+53.08%
2017-10.96+54.10%
2016-7.11-42.31%
2015-12.32N/A

Comparison Ascendis Pharma A/S (ASND) P/E with competitors

Ascendis Pharma A/S (ASND) P/E is 28.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.74%
FGENFibroGen Inc0.24-99.16%
CHRSCoherus Biosciences Inc0.85-97.03%
FBIOFortress Biotech Inc0.95-96.68%
ORMPOramed Pharmaceuticals Inc1.50-94.74%
AGENAgenus Inc3.01-89.47%
INVAInnoviva Inc3.15-88.97%
VXRTVaxart Inc3.55-87.58%
CRMDCorMedix Inc3.63-87.31%
CVACCureVac N.V.4.45-84.45%
GLPGGalapagos NV4.86-83.00%
SRPTSarepta Therapeutics Inc4.88-82.92%
ABEOAbeona Therapeutics Inc5.39-81.15%
ABUSArbutus Biopharma Corp5.60-80.43%
ZVRAZevra Therapeutics Inc5.89-79.41%
SPROSpero Therapeutics Inc6.23-78.21%
CGENCompugen Ltd6.31-77.91%
RIGLRigel Pharmaceuticals6.87-75.96%
SLXNSilexion Therapeutics Corp7.30-74.48%
OMEROmeros Corporation9.26-67.61%
AUPHAurinia Pharmaceuticals Inc9.58-66.47%
PLXProtalix BioTherapeutics Inc10.89-61.90%
ACADAcadia Pharmaceuticals Inc11.73-58.97%
TBPHTheravance Biopharma Inc12.26-57.11%
ADMAAdma Biologics Inc12.42-56.56%
HRMYHarmony Biosciences Holdings Inc13.82-51.66%
SABSSAB Biotherapeutics Inc14.14-50.55%
NAGENiagen Bioscience Inc14.82-48.17%
INCYIncyte Corp15.82-44.65%
REGNRegeneron Pharmaceuticals Inc15.86-44.53%
PBYIPuma Biotechnology Inc17.32-39.43%
CPRXCatalyst Pharmaceuticals Inc17.44-39.00%
EXELExelixis Inc17.54-38.65%
TGTXTG Therapeutics Inc18.97-33.66%
MDXGMimedx Group Inc20.55-28.11%
XOMAXOMA Royalty Corp22.87-19.98%
ARGXArgen X SE24.30-15.01%
CTMXCytomX Therapeutics Inc24.82-13.18%
XOMAOXOMA Royalty Corp25.34-11.34%
HALOHalozyme Therapeutics Inc25.62-10.37%
XOMAPXOMA Royalty Corp25.67-10.21%
VRTXVertex Pharmaceuticals Inc27.99-2.07%
RPRXRoyalty Pharma plc - Class A28.69+0.35%
SLNOSoleno Therapeutics Inc29.02+1.50%
LGNDLigand Pharmaceuticals Inc - Class B37.91+32.62%
APLSApellis Pharmaceuticals Inc39.02+36.50%
BMRNBiomarin Pharmaceutical Inc42.21+47.66%
KRYSKrystal Biotech Inc45.34+58.61%
ONCBeiGene Ltd69.54+143.25%
PHARPharming Group N.V.75.03+162.44%
TECHBio-Techne Corp101.96+256.65%
VCELVericel Corp109.92+284.51%
ALNYAlnylam Pharmaceuticals Inc117.96+312.64%
GMABGenmab140.29+390.74%
TLXTelix Pharmaceuticals Ltd162.15+467.21%
CORTCorcept Therapeutics Inc212.86+644.58%